Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2007-10-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/JAMA.298.13.1517PMID 17911496
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Systolic and diastolic heart failure in the community.

  2006cited by this paper
• ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines

  2006cited by this paper
• Disparities in the use of primary prevention and defibrillator therapy among blacks and women.

  2006influential reference
• Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data

  2005influential reference
• Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

  2005cited by this paper
• Accuracy of ICD-9-CM Codes for Identifying Cardiovascular and Stroke Risk Factors

  2005cited by this paper
• Trends in implantable cardioverter-defibrillator racial disparity: the importance of geography.

  2005cited by this paper
• Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

  2005cited by this paper
• Primary care physicians who treat blacks and whites.

  2004cited by this paper
• Adjusted survival curves with inverse probability weights

  2004cited by this paper
• Influence of Gender on Arrhythmia Characteristics and Outcome in the Multicenter UnSustained Tachycardia Trial

  2004cited by this paper
• Primary care physicians who treat blacks and whites.

  2004cited by this paper
• Utilization of implantable cardioverter-defibrillators in survivors of cardiac arrest in the United States from 1996 to 2001.

  2004cited by this paper
• Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials.

  2003cited by this paper
• Implantable Cardioverter Defibrillators in Primary and Secondary Prevention

  2003cited by this paper
• Management of ventricular arrhythmias in diverse populations in California.

  2002cited by this paper
• Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

  2002cited by this paper
• Utilization and outcomes of the implantable cardioverter defibrillator, 1987 to 1995.

  2002cited by this paper
• PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION

  2002cited by this paper
• Life-threatening ventricular arrhythmias due to transient or correctable causes: high risk for death in follow-up.

  2001cited by this paper
• Sudden Cardiac Death: Exploring the Limits of Our Knowledge

  2001cited by this paper
• Sudden Cardiac Death in the United States, 1989 to 1998

  2001cited by this paper
• Race and sex differences in the management of coronary artery disease.

  2000cited by this paper
• Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia.

  1997cited by this paper
• A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

  1997cited by this paper
• Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.

  1996cited by this paper
• A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk

  1988cited by this paper
• Analysis of survival by tumor response.

  1986cited by this paper
• Analysis of survival by tumor response.

  1983cited by this paper

• Exploring Sex and Clinical Factors Associated with Long-Term Survival After Implantable Cardioverter-Defibrillator Implantation: A 10-Year Cohort Study

  2026cites this paper
• Social Determinants of Health‐Related Outcomes in an Intervention Following Initial Implantable Cardioverter‐Defibrillator Implantation

  2025cites this paper
• Sex differences in cardiac sarcoidosis

  2025cites this paper
• Do gender differences persist in ICD implantation in patients with acute on chronic heart failure?

  2025cites this paper
• Heart Failure in Lebanon: A Glimpse into the Reality of Growing Burden

  2025cites this paper
• Impact of sex on the utilization of defibrillation-capable cardiac implantable devices and outcome: results from the German device registry.

  2025cites this paper
• Differences in presentation, diagnosis and management of heart failure in women. A scientific statement of the Heart Failure Association of the ESC

  2024cites this paper
• Patient characteristics, predictors and outcome of pacemaker patients upgraded to an implantable cardioverter defibrillator

  2024cites this paper
• Sex differences among subcutaneous implantable cardioverter-defibrillator recipients: a propensity-matched, multicentre, international analysis from the i-SUSI project

  2024cites this paper
• Sex-Related Differences and Influence of Pregnancy in Transposition of Great Arteries With Systemic Right Ventricle

  2024cites this paper
• Disparities in the implantation of secondary prevention implantable cardioverter defibrillator in the United States

  2024cites this paper
• Sex-related similarities and differences in responses to heart failure therapies

  2024cites this paper
• Iron Deficiency Among Hospitalized Patients With Congestive Heart Failure

  2024cites this paper
• Closing the sex gap in cardiovascular mortality by achieving both horizontal and vertical equity.

  2024cites this paper
• Sex Differences in Outcomes of Patients with an Implantable Cardioverter-Defibrillator for the Secondary Prevention of Sudden Cardiac Death

  2024cites this paper
• Factors Associated With Non-Uptake of Implantable Cardioverter-Defibrillator (ICD) Among Eligible Patients at a Tertiary Hospital in Kenya

  2024cites this paper
• Advancing the access to cardiovascular diagnosis and treatment among women with cardiovascular disease: a joint British Cardiovascular Societies’ consensus document

  2024cites this paper
• Cardiovascular Disease and Sex

  2023cites this paper
• Sex and Gender Differences in Ventricular Arrhythmias

  2023cites this paper
• Sex and gender differences in myocarditis and dilated cardiomyopathy: An update

  2023cites this paper
• Disparities in Referral and Utilization of Implantable Cardioverter Defibrillators for Primary Prevention of Sudden Cardiac Death.

  2023cites this paper
• Outcomes following implantable cardioverter defibrillator insertion in patients 80 years old or older: a statewide population cohort study.

  2023cites this paper
• Exploring Heart Failure Mortality Trends and Disparities in Women: A Retrospective Cohort Analysis.

  2023cites this paper
• Trends in cardiac implantable electronic device utilization in adults with congenital heart disease: a US nationwide analysis

  2023cites this paper
• Long term mortality in patients with hypertrophic cardiomyopathy – A Danish nationwide study

  2022cites this paper
• Sex Differences in Use and Response to Cardiac Rhythm Management Devices.

  2022cites this paper
• Sex Differences in Sustained Ventricular Arrhythmias: A Continuing Dialogue.

  2022cites this paper
• Posicionamento sobre a Saúde Cardiovascular nas Mulheres – 2022

  2022cites this paper
• Evolution of Devices to Prevent Sudden Cardiac Death: Contemporary Clinical Impacts.

  2022cites this paper
• Underrepresentation of women in implantable cardioverter defibrillator trials

  2022influential citation
• Variation in regional implantation patterns of cardiac implantable electronic device in Switzerland

  2022cites this paper
• Geschlechtsspezifische Unterschiede in der Kardiologie

  2022cites this paper
• Sex‐Based Differences in Selected Cardiac Implantable Electronic Device Use: A 10‐Year Statewide Patient Cohort

  2022cites this paper
• Inequality between women and men in ICD implantation

  2022cites this paper
• Heart Failure Subtypes and Cardiomyopathies in Women

  2022cites this paper
• Sex Differences in Outcomes of Tetralogy of Fallot Patients With Implantable Cardioverter-Defibrillators.

  2022cites this paper
• The Canadian Women’s Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 6: Sex- and Gender-Specific Diagnosis and Treatment

  2022cites this paper
• Recurrent Out-of-Hospital Sudden Cardiac Arrest: Prevalence and Clinical Factors

  2022cites this paper
• Impact of an Automated Best Practice Alert on Sex and Race Disparities in Implantable Cardioverter‐Defibrillator Therapy

  2022cites this paper
• Are We Underutilizing ICDs in Women With Tetralogy of Fallot?

  2022cites this paper
• Sex Differences in the Risk of First and Recurrent Ventricular Tachyarrhythmias Among Patients Receiving an Implantable Cardioverter-Defibrillator for Primary Prevention

  2022cites this paper
• Position Statement on Women ’ s Cardiovascular Health – 2022

  2022cites this paper
• Arrhythmias in Female Patients: Incidence, Presentation and Management.

  2022cites this paper
• Why We Need Specialised Centres for Women’s Hearts: Changing the Face of Cardiovascular Care for Women

  2021cites this paper
• Ventricular Arrhythmias

  2021cites this paper
• Gender Differences in Implantable Cardioverter-Defibrillator Utilization for Primary Prevention of Sudden Cardiac Death

  2021cites this paper
• Sex Differences in Heart Failure.

  2021cites this paper
• Heart Failure With Reduced Ejection Fraction

  2021cites this paper
• The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030.

  2021cites this paper
• Sex/gender and additional equity characteristics of providers and patients in perioperative anesthesia trials: a cross-sectional analysis of the literature

  2021cites this paper
• Sex and Race Disparities in Hypertrophic Cardiomyopathy: Unequal Implantable Cardioverter-Defibrillator Use During Hospitalization.

  2021cites this paper
• Acute myocardial infarction and cardiogenic shock arrhythmias

  2020cites this paper
• Sex differences in implantable cardioverter defibrillators

  2020cites this paper
• Sex-specific arrhythmia risk of post-MI follow-up

  2020cites this paper
• Clinical and Hospital Factors Affecting Treatment with Primary Prevention Implantable Cardioverter-Defibrillators in Ischemic Cardiomyopathy Patients

  2020cites this paper
• Implantable Cardioverter Defibrillator Utilization and Mortality Among Patients ≥ 65 Years of Age with a Low Ejection Fraction Following Coronary Revascularization.

  2020cites this paper
• Impact of physician’s sex/gender on processes of care, and clinical outcomes in cardiac operative care: a systematic review

  2020cites this paper
• Sex and Gender Differences in Heart Failure

  2020cites this paper
• Going, gonad, gone. Gender inequalities in the management of gonadal torsion: a cohort study

  2020cites this paper
• State of the Science in Women's Cardiovascular Disease: A Canadian Perspective on the Influence of Sex and Gender

  2020cites this paper
• Sex/gender and additional equity characteristics of providers and patients in perioperative anesthesia trials: a cross-sectional analysis of the literature

  2020cites this paper
• Sex Influence on Heart Failure Prognosis

  2020cites this paper
• Cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy: single center implant data extracted from the Swedish pacemaker and ICD registry

  2020cites this paper
• Contemporary use of devices in chronic heart failure in the Netherlands

  2020cites this paper
• Sex-Specific Outcomes in Cardiovascular Device Evaluations

  2020cites this paper
• Ten‐year trends in cardiac implantable electronic devices in New Zealand: a national data linkage study (ANZACS‐QI 51)

  2020cites this paper
• Sex Differences in Advanced Heart Failure Therapies

  2019cites this paper
• Sex-Related Differences in Use and Outcomes of Left Ventricular Assist Devices as Bridge to Transplantation.

  2019cites this paper
• Does sex modify an association of electrophysiological substrate with sudden cardiac death? The Atherosclerosis Risk in Communities (ARIC) study

  2019cites this paper
• Comparison of Long-Term Survival Following Sudden Cardiac Arrest in Men Versus Women.

  2019cites this paper
• Sex Disparities in Cardiovascular Device Evaluations: Strategies for Recruitment and Retention of Female Patients in Clinical Device Trials.

  2019cites this paper
• Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy in Women.

  2019cites this paper
• Editorial commentary: Ethnic and racial disparities and differences in sudden cardiac death burden and survival: How do we close the gap?

  2019cites this paper
• Implantable cardioverter defibrillator for the prevention of sudden cardiac death: Systematic review and pooled analysis

  2019cites this paper
• Considering the gender gap in heart failure

  2019cites this paper
• SUPRAVENTRICULAR TACHYCARDIA Atrial Fibrillation and Atrial Flutter Disease

  2018cites this paper
• Five year trends (2008–2012) in cardiac implantable electrical device utilization in five European nations: a case study in cross-country comparisons using administrative databases

  2018cites this paper
• Sex Differences in the Management of Advanced Heart Failure

  2018cites this paper
• Sex Differences in Cardiac Arrhythmias

  2018cites this paper
• Referral, Appropriateness and Eligibility of Implantable Cardioverter Defibrillator Therapy in Alberta

  2018cites this paper
• Sex Differences in Heart Failure.

  2018cites this paper
• Atrio-ventricular junction ablation and pacemaker treatment: a comparison between men and women

  2018cites this paper
• Sex Differences in Cardiac Arrhythmias: Clinical and Research Implications

  2018cites this paper
• Exploring the patients’ experiences of living with a subcutaneous implantable cardioverter defibrillator

  2018cites this paper
• Cardiac implantable electrical devices in women

  2018cites this paper
• Trends and predictors of implantable cardioverter defibrillator implantation after sudden cardiac arrest: Insight from the national inpatient sample

  2018cites this paper
• Implantable cardioverter defibrillators: Uses, abuses, gains and complications

  2017cites this paper
• Utilization of cardiac resynchronization therapy in eligible patients hospitalized for heart failure and its association with patient outcomes

  2017cites this paper
• Occurence of implantable cardioverter-defi brillator therapy in clinical practice

  2017influential citation
• Chapter 8 – Implantable Cardioverter Defibrillators

  2017influential citation
• Gender differences in management and clinical outcomes of atrial fibrillation patients.

  2017cites this paper
• Sudden Cardiac Death: Lessons Learned from Cardiac Implantable Rhythm Devices.

  2017cites this paper
• Implantable-cardioverter-defibrillator : clinical advancements in individualized and targeted treatment

  2017cites this paper
• Implantable Cardioverter-Defibrillator of Korean Patients in a Single Center Registry

  2017cites this paper
• 2016 AHA/ACC Clinical Performance and Quality Measures for Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures

  2017influential citation
• Because Women's Lives Matter, We Need to Eliminate Gender Bias.

  2017cites this paper
• Atrial Fibrillation and Ventricular Arrhythmias Sex Differences in Electrophysiology, Epidemiology, Clinical Presentation, and Clinical Outcomes IN DEPTH

  2017cites this paper
• Atrial Fibrillation and Ventricular Arrhythmias Sex Differences in Electrophysiology

  2017cites this paper
• 2016 AHA/ACC Clinical Performance and Quality Measures for Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.

  2017cites this paper
• The effects of gender on electrical therapies for the heart: physiology, epidemiology, and access to therapies

  2017cites this paper